Cavalli R - Search Results

1

Nocturnal anomalous movement reduction and sleep microstructure analysis in parkinsonian patients during 1-night transdermal apomorphine treatment.

Priano L, Albani G, Brioschi A, Guastamacchia G, Calderoni S, Lopiano L, Rizzone M, Cavalli R, Gasco MR, Fraschini F, Bergamasco B, Mauro A. Priano L, et al. Among authors: cavalli r. Neurol Sci. 2003 Oct;24(3):207-8. doi: 10.1007/s10072-003-0133-z. Neurol Sci. 2003. PMID: 14598090 Free article.

2

Transdermal apomorphine permeation from microemulsions: a new treatment in Parkinson's disease.

Priano L, Albani G, Brioschi A, Calderoni S, Lopiano L, Rizzone M, Cavalli R, Gasco MR, Scaglione F, Fraschini F, Bergamasco B, Mauro A. Priano L, et al. Among authors: cavalli r. Mov Disord. 2004 Aug;19(8):937-42. doi: 10.1002/mds.20054. Mov Disord. 2004. PMID: 15300660 Free article. Clinical Trial.

3

Controlled-release transdermal apomorphine treatment for motor fluctuations in Parkinson's disease.

Priano L, Albani G, Calderoni S, Baudo S, Lopiano L, Rizzone M, Astolfi V, Cavalli R, Gasco MR, Fraschini F, Bergamasco B, Mauro A. Priano L, et al. Among authors: cavalli r. Neurol Sci. 2002 Sep;23 Suppl 2:S99-100. doi: 10.1007/s100720200088. Neurol Sci. 2002. PMID: 12548362 Clinical Trial.

4

Incorporation of cyclosporin A in solid lipid nanoparticles (SLN).

Ugazio E, Cavalli R, Gasco MR. Ugazio E, et al. Among authors: cavalli r. Int J Pharm. 2002 Jul 25;241(2):341-4. doi: 10.1016/s0378-5173(02)00268-5. Int J Pharm. 2002. PMID: 12100861

5

Preparation and characterization of solid lipid nanospheres containing paclitaxel.

Cavalli R, Caputo O, Gasco MR. Cavalli R, et al. Eur J Pharm Sci. 2000;10(4):305-9. doi: 10.1016/s0928-0987(00)00081-6. Eur J Pharm Sci. 2000. PMID: 10838020

6

Timolol in lipospheres.

Gasco MR, Cavalli R, Carlotti ME. Gasco MR, et al. Among authors: cavalli r. Pharmazie. 1992 Feb;47(2):119-21. Pharmazie. 1992. PMID: 1635918

7

Scale-up of the preparation process of solid lipid nanospheres. Part I.

Marengo E, Cavalli R, Caputo O, Rodriguez L, Gasco MR. Marengo E, et al. Among authors: cavalli r. Int J Pharm. 2000 Sep 15;205(1-2):3-13. doi: 10.1016/s0378-5173(00)00471-3. Int J Pharm. 2000. PMID: 11000537

8

Evaporative drying of aqueous dispersions of solid lipid nanoparticles.

Cavalli R, Gasco MR, Barresi AA, Rovero G. Cavalli R, et al. Drug Dev Ind Pharm. 2001 Oct;27(9):919-24. doi: 10.1081/ddc-100107672. Drug Dev Ind Pharm. 2001. PMID: 11763469

9

Use of polymeric and non-polymeric surfactants in o/w emulsion formulation.

Carlotti ME, Pattarino F, Gasco MR, Cavalli R. Carlotti ME, et al. Among authors: cavalli r. Int J Cosmet Sci. 1995 Feb;17(1):13-25. doi: 10.1111/j.1467-2494.1995.tb00105.x. Int J Cosmet Sci. 1995. PMID: 19250476

10

Duodenal administration of solid lipid nanoparticles loaded with different percentages of tobramycin.

Cavalli R, Bargoni A, Podio V, Muntoni E, Zara GP, Gasco MR. Cavalli R, et al. J Pharm Sci. 2003 May;92(5):1085-94. doi: 10.1002/jps.10368. J Pharm Sci. 2003. PMID: 12712429

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

464 results

Search Page

Filters